This inventor holds 1 USPTO granted patent. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985
Title: Mitsuru Nakayama: Innovator in Diabetes Treatment
Introduction
Mitsuru Nakayama is a notable inventor based in Hiroshima, Japan. He has made significant contributions to the field of diabetes treatment through his innovative research and development.
Latest Patents
Mitsuru Nakayama holds a patent for an inhibitor of aldose reductase. This inhibitor contains, as the effective ingredient, a flavone derivative that is designed to prevent, reduce, or treat complications associated with diabetes. The specific formula includes variations of hydrogen atoms, hydroxyl groups, and methoxyl groups, along with a pharmaceutically acceptable carrier.
Career Highlights
Mitsuru Nakayama is affiliated with Kaken Pharmaceutical Company, Ltd., where he has been instrumental in advancing research related to diabetes. His work has led to the development of effective treatments that can improve the quality of life for individuals suffering from this condition.
Collaborations
Mitsuru Nakayama has collaborated with notable colleagues such as Kazuhiro Inagaki and Ichitomo Miwa. Their combined expertise has contributed to the success of their projects and innovations in the pharmaceutical field.
Conclusion
Mitsuru Nakayama's contributions to diabetes treatment through his innovative patent highlight the importance of research in improving health outcomes. His work continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile